Expanded Access to Velmanase Alfa

International Registry for Patients With Castleman Disease

NCT02817997 ·Status: RECRUITING

Monthly Dosing of Atacicept in IgAN

NCT07020923 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05809531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

NCT01730495 ·Status: TERMINATED ·Phase: PHASE2

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

NCT06720870 ·Status: RECRUITING

A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency

NCT05154890 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis

NCT02910258 ·Status: COMPLETED

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

NCT01242813 ·Status: COMPLETED ·Phase: PHASE2

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

NCT02108860 ·Status: COMPLETED ·Phase: PHASE3

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

NCT02878603 ·Status: COMPLETED ·Phase: PHASE3

1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement

NCT02756650 ·Status: COMPLETED ·Phase: PHASE2

Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis

NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

NCT04244916 ·Status: TERMINATED

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

NCT02004691 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386 ·Status: RECRUITING ·Phase: PHASE3

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

NCT00755859 ·Status: COMPLETED ·Phase: PHASE4

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

NCT04817618 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

NCT05917561 ·Status: RECRUITING ·Phase: PHASE2

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

NCT00001764 ·Status: COMPLETED ·Phase: PHASE1

Phase III Study in Refractory Behcet's Disease

NCT00995709 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155 ·Status: COMPLETED ·Phase: PHASE2

Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo

NCT03859518 ·Status: COMPLETED

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

NCT01539902 ·Status: UNKNOWN ·Phase: PHASE2

Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis

NCT00441961 ·Status: COMPLETED ·Phase: NA